Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07728097) titled 'A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGS' on July 22.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Jazz Pharmaceuticals
Condition:
Lennox-Gastaut Syndrome
Intervention:
Drug: Cannabidiol Oral Solution
Recruitment Status: Not recruiting
Phase: Phase 4
Date of First Enrollment: November 18, 2026
Target Sample Size: 40
Countries of Recruitment:
United States
To know more, visit https://clinicaltrials.gov/study/...